Murine monoclonal antibody combining site to human C3b receptor (CR1)
US4672044A · kind A · utility
19Cited by
3References
16Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 24, 1984 |
| Grant date | Jun 9, 1987 |
| Priority date | — |
| Expiry date | Aug 24, 2004 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S436/821
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A murine monoclonal antibody combining site produced by a hybridoma formed by fusion of cells from a myeloma cell line and lymphocytes that produce antibodies that react (1) with isolated human C3b receptor and (2) with C3b receptor-bearing cells from a mammal immunized with human C3b receptor is disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.